ClinicalTrials.govpublic full text
A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
autoimmune hemolytic anemia, anti-cd19 star t-cell therapy, failure ≥3 lines of therapies, relapsed/refractory autoimmune hemolytic anemia, cd19-star t cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869671
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.